AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

PHASE2TerminatedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Neuropathic PainMechanical Hypersensitivity
Interventions
DRUG

AZD2066

Capsule, once daily

DRUG

Placebo

Capsule, once daily

Trial Locations (38)

Unknown

Research Site, Tucson

Research Site, Los Angeles

Research Site, Sacramento

Research Site, San Francisco

Research Site, Walnut Creek

Research Site, Boulder

Research Site, Atlantis

Research Site, Aventura

Research Site, Clearwater

Research Site, Fort Myers

Research Site, Orlando

Research Site, Palm Beach Gardens

Research Site, Sarasota

Research Site, St. Petersburg

Research Site, Sunrise

Research Site, Canton

Research Site, Marietta

Research Site, Evansville

Research Site, New Orleans

Research Site, Brockton

Research Site, Bingham Farms

Research Site, Las Vegas

Research Site, Reno

Research Site, Lumberton

Research Site, Willingboro

Research Site, Albuquerque

Research Site, Jacksonville

Research Site, Winston-Salem

Research Site, Kettering

Research Site, Portland

Research Site, Bridgeville

Research Site, Philadelphia

Research Site, Austin

Research Site, Dallas

Research Site, Irving

Research Site, Lexington

Research Site, Longview

Research Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY